XML 81 R36.htm IDEA: XBRL DOCUMENT v2.3.0.15
Quarterly Financial Data (Tables)
12 Months Ended
Dec. 31, 2010
Quarterly Financial Data (Unaudited) (Tables) [Abstract] 
Unaudited Quarterly Financial Data
                                 
    Quarters  

(in millions, except per share data)

   First(3)     Second     Third     Fourth  

Fiscal 2010 (1)

                                

Total revenues (2)

   $ 11,138.4     $ 11,288.8     $ 11,251.8     $ 11,294.2  

Cost of revenues (2)

     10,475.2       10,531.3       10,487.7       10,520.8  
   

 

 

    

 

 

    

 

 

    

 

 

  

Gross profit

     663.2       757.5       764.1       773.4  

Selling, general and administrative

     208.5       227.2       236.1       215.5  
   

 

 

    

 

 

    

 

 

    

 

 

  

Operating income

     454.7       530.3       528.0       557.9  

Net income from continuing operations

     260.6       307.3       307.1       329.6  

Net loss from discontinued operations, net of tax

     (0.4 )      (17.4 )      (5.6 )      —    
   

 

 

    

 

 

    

 

 

    

 

 

  

Net income

   $ 260.2     $ 289.9     $ 301.5     $ 329.6  

Basic earnings (loss) per share:

                                

Continuing operations

   $ 0.47     $ 0.56     $ 0.58     $ 0.62  

Discontinued operations

     —         (0.03 )      (0.01 )      —    

Net earnings

     0.47       0.53       0.57       0.62  

Diluted earnings (loss) per share:

                                

Continuing operations

   $ 0.47     $ 0.56     $ 0.57     $ 0.62  

Discontinued operations

     —         (0.03 )      (0.01 )      —    

Net earnings

     0.47       0.53       0.56       0.62  

Fiscal 2009 (1) (3)

                                

Total revenues (2)

   $ 5,415.5     $ 5,496.8     $ 5,613.0     $ 8,197.0  

Cost of revenues (2)

     4,882.9       4,904.2       5,001.9       7,509.3  
   

 

 

    

 

 

    

 

 

    

 

 

  

Gross profit

     532.6       592.6       611.1       687.7  

Selling, general and administrative

     177.3       212.4       252.7       284.1  
   

 

 

    

 

 

    

 

 

    

 

 

  

Operating income

     355.3       380.2       358.4       403.6  

Net income from continuing operations

     214.6       192.1       196.8       223.1  

Net (loss) income from discontinued operations, net of tax

     (0.2 )      0.2       0.8       0.2  
   

 

 

    

 

 

    

 

 

    

 

 

  

Net income

   $ 214.4     $ 192.3     $ 197.6     $ 223.3  

Basic earnings per share:

                                

Continuing operations

   $ 0.43     $ 0.37     $ 0.36     $ 0.41  

Discontinued operations

     —         —         —         —    

Net earnings

     0.43       0.37       0.36       0.41  

Diluted earnings per share:

                                

Continuing operations

   $ 0.43     $ 0.37     $ 0.35     $ 0.40  

Discontinued operations

     —         —         —         —    

Net earnings

     0.43       0.37       0.36       0.40  

 

(1) Includes the December 1, 2009 acquisition of NextRx.
(2) Includes retail pharmacy co-payments of $1,662.6 and $822.7 for the three months ended March 31, 2010 and 2009, respectively, $1,547.3 and $721.1 for the three months ended June 30, 2010 and 2009, respectively, $1,478.5 and $708.4 for the three months ended September 30, 2010 and 2009, respectively, and $1,493.0 and $879.9 for the three months ended December 31, 2010 and 2009, respectively.
(3) Restated to exclude the discontinued operations of PMG